Pin Oak Investment Advisors Inc. Has $76,000 Holdings in Zoetis Inc. (NYSE:ZTS)

by · The Markets Daily

Pin Oak Investment Advisors Inc. lifted its position in shares of Zoetis Inc. (NYSE:ZTS – Free Report) by 34.4% during the 1st quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 461 shares of the company’s stock after purchasing an additional 118 shares during the quarter. Pin Oak Investment Advisors Inc.’s holdings in Zoetis were worth $76,000 as of its most recent filing with the Securities and Exchange Commission.

Several other large investors also recently modified their holdings of ZTS. Navigoe LLC bought a new stake in shares of Zoetis in the 4th quarter valued at approximately $30,000. Cornerstone Planning Group LLC grew its position in Zoetis by 79.3% during the 1st quarter. Cornerstone Planning Group LLC now owns 199 shares of the company’s stock worth $30,000 after acquiring an additional 88 shares during the last quarter. Migdal Insurance & Financial Holdings Ltd. grew its position in Zoetis by 87.6% during the 1st quarter. Migdal Insurance & Financial Holdings Ltd. now owns 257 shares of the company’s stock worth $42,000 after acquiring an additional 120 shares during the last quarter. Sound Income Strategies LLC grew its position in Zoetis by 141.4% during the 1st quarter. Sound Income Strategies LLC now owns 280 shares of the company’s stock worth $46,000 after acquiring an additional 164 shares during the last quarter. Finally, Bfsg LLC grew its position in Zoetis by 614.6% during the 1st quarter. Bfsg LLC now owns 293 shares of the company’s stock worth $48,000 after acquiring an additional 252 shares during the last quarter. 92.80% of the stock is currently owned by institutional investors.

Insider Activity

In other Zoetis news, EVP Roxanne Lagano sold 652 shares of Zoetis stock in a transaction dated Tuesday, June 3rd. The stock was sold at an average price of $170.00, for a total value of $110,840.00. Following the sale, the executive vice president owned 15,129 shares of the company’s stock, valued at $2,571,930. This trade represents a 4.13% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through the SEC website. 0.16% of the stock is owned by corporate insiders.

Analyst Upgrades and Downgrades

A number of research analysts have commented on ZTS shares. UBS Group decreased their price objective on Zoetis from $189.00 to $170.00 and set a “neutral” rating on the stock in a research report on Wednesday, May 7th. Stifel Nicolaus lowered Zoetis from a “buy” rating to a “hold” rating and decreased their price objective for the company from $165.00 to $160.00 in a research report on Wednesday, June 18th. Piper Sandler increased their price objective on Zoetis from $205.00 to $210.00 and gave the company an “overweight” rating in a research report on Monday, May 12th. Leerink Partnrs lowered Zoetis from a “strong-buy” rating to a “hold” rating in a research report on Thursday, July 17th. Finally, Leerink Partners lowered Zoetis from an “outperform” rating to a “market perform” rating and decreased their price objective for the company from $180.00 to $155.00 in a research report on Thursday, July 17th. Four analysts have rated the stock with a hold rating, six have given a buy rating and one has issued a strong buy rating to the stock. According to data from MarketBeat.com, Zoetis has an average rating of “Moderate Buy” and an average target price of $204.63.

Read Our Latest Stock Analysis on Zoetis

Zoetis Stock Performance

Shares of Zoetis stock opened at $151.92 on Monday. The company has a market capitalization of $67.64 billion, a PE ratio of 27.28, a PEG ratio of 2.52 and a beta of 0.91. Zoetis Inc. has a 12 month low of $139.70 and a 12 month high of $200.33. The company has a current ratio of 1.74, a quick ratio of 1.04 and a debt-to-equity ratio of 1.12. The stock’s fifty day simple moving average is $159.91 and its 200 day simple moving average is $160.96.

Zoetis (NYSE:ZTS – Get Free Report) last issued its quarterly earnings data on Tuesday, May 6th. The company reported $1.48 EPS for the quarter, topping the consensus estimate of $1.40 by $0.08. The business had revenue of $2.22 billion for the quarter, compared to the consensus estimate of $2.20 billion. Zoetis had a return on equity of 55.48% and a net margin of 27.12%. The firm’s revenue was up 1.4% compared to the same quarter last year. During the same quarter last year, the business posted $1.38 EPS. On average, research analysts predict that Zoetis Inc. will post 6.07 EPS for the current year.

Zoetis Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Wednesday, September 3rd. Shareholders of record on Friday, July 18th will be paid a $0.50 dividend. This represents a $2.00 annualized dividend and a dividend yield of 1.32%. The ex-dividend date of this dividend is Friday, July 18th. Zoetis’s dividend payout ratio is 35.91%.

Zoetis Profile

(Free Report)

Zoetis Inc engages in the discovery, development, manufacture, and commercialization of animal health medicines, vaccines, and diagnostic products and services in the United States and internationally. The company commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep and others; and companion animals comprising dogs, cats, and horses.

Featured Articles

Want to see what other hedge funds are holding ZTS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Zoetis Inc. (NYSE:ZTS – Free Report).